STRATA Skin Sciences Inc (NASDAQ:SSKN) has received an average broker rating score of 1.00 (Strong Buy) from the three brokers that cover the stock, Zacks Investment Research reports. Three research analysts have rated the stock with a strong buy recommendation.
Brokers have set a twelve-month consensus price objective of $5.67 for the company and are predicting that the company will post ($0.01) earnings per share for the current quarter, according to Zacks. Zacks has also assigned STRATA Skin Sciences an industry rank of 86 out of 256 based on the ratings given to its competitors.
SSKN has been the subject of a number of research analyst reports. HC Wainwright set a $73.00 target price on shares of Uniqure and gave the company a “buy” rating in a research note on Monday, July 8th. Northland Securities set a $5.00 target price on shares of Communications Systems and gave the company a “buy” rating in a research note on Tuesday, May 14th. Zacks Investment Research upgraded shares of York Water from a “sell” rating to a “hold” rating in a research note on Saturday, June 1st. Finally, ValuEngine cut shares of Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd.
Several institutional investors have recently modified their holdings of SSKN. Northern Trust Corp purchased a new stake in shares of STRATA Skin Sciences during the fourth quarter worth $36,000. Virtu Financial LLC purchased a new stake in shares of STRATA Skin Sciences during the first quarter worth $39,000. Finally, Meitav Dash Investments Ltd. raised its holdings in shares of STRATA Skin Sciences by 12.8% during the first quarter. Meitav Dash Investments Ltd. now owns 807,234 shares of the medical device company’s stock worth $2,314,000 after acquiring an additional 91,418 shares in the last quarter. 30.96% of the stock is owned by institutional investors and hedge funds.
SSKN traded down $0.04 during midday trading on Friday, reaching $2.55. 105 shares of the company’s stock were exchanged, compared to its average volume of 38,271. STRATA Skin Sciences has a one year low of $1.76 and a one year high of $3.88. The company’s 50-day moving average is $2.38.
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.
Further Reading: What are earnings reports?
Get a free copy of the Zacks research report on STRATA Skin Sciences (SSKN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.